+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Polio Drug"

Poliomyelitis - Pipeline Insight, 2025 - Product Thumbnail Image

Poliomyelitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Poliomyelitis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Poliomyelitis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Poliomyelitis Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Poliomyelitis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

The Polio Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat and prevent polio, a highly contagious viral infection that can cause paralysis and even death. Polio drugs are typically administered orally or by injection, and can be used to treat both acute and chronic cases of the disease. The most common polio drugs are inactivated poliovirus vaccine (IPV), oral poliovirus vaccine (OPV), and monoclonal antibodies. The Polio Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Sanofi, GlaxoSmithKline, Merck, Pfizer, and Novartis. Other companies such as Emergent BioSolutions, Emergent Vaccines, and Bharat Biotech are also active in the market. Show Less Read more